MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KR-03-0211068
Supraceuticals Private Limited
Supraceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.37 Cr
Latest filing
Net loss · FY 2024
₹79.79 Lakh
Net margin -33.6%
EBITDA · FY 2024
-₹79.98 Lakh
EBITDA margin -33.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6.25 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Employees · EPFO
20
Provident fund records
Directors on board
5
As per MCA filings
About Supraceuticals Private Limited
Data last updated:
Supraceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2022PTC166848.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.25 Lakh. It is led by directors including Singatagere Chandrappa Venkatesha Murthy and Melige Ahmed Ashraf.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.37 Cr. For the same year it recorded a net loss of ₹79.79 Lakh (net margin -33.6%) and EBITDA of -₹79.98 Lakh (EBITDA margin -33.7%).
The company has about 20 employees on its provident fund (EPFO) records.
Supraceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0211068). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Supraceuticals Private Limited
CIN U24290KA2022PTC166848
Registration Number 166848
Incorporation Date 10 October 2022
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0211068
Key People
Singatagere Chandrappa Venkatesha Murthy Director Melige Ahmed Ashraf Director Prashanthkulkarni Director Recognitions & Rankings of Supraceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.20 Shop No.3 Ground Floor 1st A Main 2nd Cross Aditya Nagar J.P Nagar 8th P, Hase, Bangalore, Karnataka, India – 560062
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Supraceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Supraceuticals Private Limited
The main business activity of Supraceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Supraceuticals Private Limited FY 2025 filings available
Supraceuticals Private Limited reported revenue of ₹2.37 Cr for FY 2024.
Revenue · FY 2024
₹2.37 Cr
Net loss · FY 2024
₹79.79 Lakh margin -33.6%
EBITDA · FY 2024
-₹79.98 Lakh margin -33.7%
Financial Statement Summary of Supraceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹79.98 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹79.79 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Supraceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -33.7% | •••• |
| Net Profit Margin | -33.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Supraceuticals are in the company report.
Premium access
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Supraceuticals Private Limited
Supraceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Singatagere Chandrappa Venkatesha Murthy | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Melige Ahmed Ashraf | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Prashanthkulkarni | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Jayakrishnasetty Rajesh | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Ibrahim Mohammed | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
Peer Comparison of Supraceuticals Private Limited
Supraceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Simchem Private Limited | ₹2.38 Cr (FY 2024) | •••• | •••• | -50.0% | •••• | Panaji, Goa, India |
| Clyde Pharmaceutical Private Limited | ₹2.38 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Bishrakh, Uttar Pradesh, India |
| Nordea Lifescience Private Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | 207.0% | •••• | Delhi, India |
| Inovin Pharmaceuticals Private Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Manimajra, Chandigarh, India |
| Abhiru Industries Limited | ₹2.38 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Hyderabad, Telangana, India |
| Supraceuticals Private Limited this company | ₹2.37 Cr (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Apricot Labs Private Limited | ₹2.37 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Hyderabad, Telangana, India |
| Bull Pharmaceuticals Private Limited | ₹2.37 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Telangana, India |
| Levin Formulations Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| Saboori Pharma Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Telangana, India |
| Wagnerhuber Pharmaceuticals Private Limited | ₹2.36 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Supraceuticals by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Supraceuticals Private Limited
Supraceuticals Private Limited is audited by ARSV AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARSV AND ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Supraceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Supraceuticals Private Limited
Supraceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Supraceuticals Private Limited
Employment history and EPFO contributions of people linked to Supraceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Supraceuticals Private Limited
Supraceuticals Private Limited has 6 board changes on record since 2022: 5 appointments and 1 cessation. The latest: Ibrahim Mohammed ceased to be Additional Director on 30 Mar 2023.
AGM
Supraceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Supraceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Ibrahim Mohammed ceased to be Additional Director.
Appointed
Ibrahim Mohammed was appointed as Director.
Appointed
Jayakrishnasetty Rajesh was appointed as Director.
Appointed
Melige Ahmed Ashraf was appointed as Director.
Appointed
Prashanthkulkarni was appointed as Director.
Appointed
Singatagere Chandrappa Venkatesha Murthy was appointed as Director.
Incorporation
10 Oct 2022
Supraceuticals Private Limited was registered on 10 Oct 2022 with Roc Bangalore & aged 4 years 11 days as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Supraceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Supraceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Supraceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Supraceuticals Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Supraceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supraceuticals Private Limited
Supraceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 2022 (4+ years old) and is registered under CIN U24290KA2022PTC166848.
Supraceuticals reported revenue of ₹2.37 Cr for FY 2024.
Supraceuticals has 5 current directors:
- Singatagere Chandrappa Venkatesha Murthy - Director
- Melige Ahmed Ashraf - Director
- Prashanthkulkarni - Director
- Jayakrishnasetty Rajesh - Director
- Ibrahim Mohammed - Director
Supraceuticals reported a net loss of ₹79.79 Lakh (net margin -33.6%) and EBITDA of -₹79.98 Lakh (EBITDA margin -33.7%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Supraceuticals is U24290KA2022PTC166848. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supraceuticals was incorporated on 10 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Supraceuticals by revenue are Simchem Private Limited, Clyde Pharmaceutical Private Limited, Nordea Lifescience Private Limited, Inovin Pharmaceuticals Private Limited, Abhiru Industries Limited and 5 more, all in the Pharma industry (Formulations).
Ibrahim Mohammed ceased to be Additional Director on 30 Mar 2023. Ibrahim Mohammed was appointed as Director on 06 Jan 2023. Jayakrishnasetty Rajesh was appointed as Director on 10 Oct 2022. Supraceuticals has 6 board changes on record in total.
Yes, Supraceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0211068).
The registered office of Supraceuticals is at No.20 Shop No.3 Ground Floor 1st A Main 2nd Cross Aditya Nagar J.P Nagar 8th P, Hase, Bangalore, Karnataka, India – 560062.
Supraceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.25 Lakh.